Wang Xiaolin

Wang Xiaolin is listed in filings as See Remarks at Revolution Medicines, Inc. Warrant. This profile follows SEC Form 4 activity through Mar 19, 2026, including sale activity. Recent filings connect the profile to Revolution Medicines, Inc. Warrant (RVMDW) and Revolution Medicines, Inc. (RVMD). The current snapshot covers public activity from Mar 4, 2025 to Mar 19, 2026. Reported amounts are shown as $200.0K to $2.7M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.